Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group Plc LSE:DEMG London Ordinary Share GB0059337583 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 1.325 1.25 1.40 1.325 1.325 1.33 298,387 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 4.3 -0.2 -0.0 - 7

Deltex Medical Share Discussion Threads

Showing 21551 to 21573 of 21625 messages
Chat Pages: 865  864  863  862  861  860  859  858  857  856  855  854  Older
DateSubjectAuthorDiscuss
08/10/2020
08:32
Gone to sleep............
chrisdgb
29/9/2020
12:17
A few little nibbles at this bargain price, if I was a gambling man I'd say the trade @ 1.36 was an internal company buy just like the finance directors trade recently?
gbenson1
28/9/2020
09:36
Sort of. Turner Pope said "the Pandemic may have served to highlight the relevance and opportunity Deltex Medical’s preeminent Doppler technologies presents to a number of larger sector players who may wish to expand their market opportunity into this space"
schloo
28/9/2020
08:14
Can't see the note unfortunately but do Turner Pope make any mention that they still think the company could be a takeover target..??
chrisdgb
23/9/2020
06:40
hTtps://www.youtube.com/watch?v=ToQ0n3itoII
buywell3
23/9/2020
06:33
They bought a stack at the start of this year just before sales collapsed so I doubt they know much. More likely this is being done to make us think they know something and stop a wave of selling after the utterly dismal first half performanceOr it may be in a non-specific realisation that they need to make some positive changes and start finding a buyerPositive changes could include:New chairNew, smaller boardNew advisersNew monitorNew business modelNew marketing storyMaybe they are coming but I doubt itMrC
mrc2u
22/9/2020
15:15
Finance director David Moorhouse just bought 370,000 shares and I wouldn't be surprised if the other 200k buy @ 1.35 was a bod, gives you faith in the company directors buying, and do they know something?
gbenson1
21/9/2020
12:30
Turner Pope have published a note which echoes my earlier post. Potential for strong recovery with massive catch up needed on delayed surgery and they don't seem too worried about cash with grant money and some US payroll support hxxps://mcusercontent.com/d9ebd7c1aa0f3dbc5fab42eca/files/f66a1f35-38d1-4ff2-8a81-f71a1c03a1a1/Deltex_Medical_21_9_2020_FINAL_BGv2.pdf Apologies if the https gets xx's as can't remember how to fix
schloo
21/9/2020
08:44
htTps://www.youtube.com/watch?v=_oyBnvibWEY
buywell3
21/9/2020
08:11
wow - they have seen the light or realised there is nothing left to fight for
trentendboy
21/9/2020
07:39
Interims were published around the same time as last year, I'm afraid I don't get your logic about trying to sneak them out first thing on a Mon morning lol. The interims were I'll agree poor, we've seen no financial uptick due to Covid despite the increase in sales in the U.K. and France. We need a merger or takeover to push the company forward, someone with deep pockets that can invest and finance a new monitor.
gbenson1
21/9/2020
07:12
Lots of chat from senior NHS doctors that they are ready for a second surge in coronavirus but also that this time they are prepared for it and it will not disrupt major surgery If that is remotely correct, we should expect a fairly rapid uptick in probe sales run rates both from surgery getting up to speed and fro ICUs as they treat the second wave Yes, LID did much better than DEMG in Q1 but mostly through monitor sales. Unfortunate that DEMG don't have a monitor to sell but they are getting grant money to get in with it. Shouldn't be too long before they are the ones with the new toy and that is when getting the business model correct will be vital. My view is that it needs to be as close to SaaS as possible
schloo
21/9/2020
06:49
buywell is saying nothing
buywell3
21/9/2020
06:48
Was not expecting to see interim results this morning. They really should put out a notice of results and first thing on a Monday is for the bigger boys so feels like they are trying to sneak them out. That might well be the case given they hid from shareholders at AGM timeResults are dire but, I suppose, in line with what we had heard before, although any signs of a pick up in surgery are weak hearsay at best. At least France now ordering again after a 7 month blank. No comment on how LID smashed them out of the park with Q1 monitor sales: from parity with LID to selling one quarter as much remains a truly dreadful performanceDisappointing that they, yet again, have chosen not to do any of the things they could and should be doing:New chairNew, smaller boardNew advisersNew monitorNew marketing storyNew commercial modelWith furlough ending, they are going to have make redundancies, surely, to have any hope of avoiding a distressed cash call. Alarming that they say they are getting the band back togetherHappy Monday!MrC
mrc2u
21/9/2020
06:32
Why are you here if you're not interested in the company? Are you trying to make money shorting them?
jpuff
21/9/2020
06:13
Stuffed!!!! https://www.investegate.co.uk/deltex-med-grp-plc--demg-/rns/interim-results-to-30-june-2020/202009210700075050Z/
pugugly
12/9/2020
14:12
Looks like we may get some positive news on ODM in veterinary medicine. Dedicated website set up for small animals with a case study from Cornell See www.deltexveterinary.com/education/case-studies/ Big market potential: just think of people's horror at the size of bills for per surgery so a little extra to help Fido live longer and better is not much of an ask especially if insurer picks up the tab
schloo
08/9/2020
08:32
Hi mrC2u, still agree with the fact the changes are needed here, however LID has lost over 20% in value over the last 3-4 weeks so much for HUP!!
gbenson1
08/9/2020
07:58
Second half of this month. They have to put them out within 90 days but tend to be very slow these days. Suspect they are waiting as long as possible to see if anything good happens, like a resurgence from a surge in surgeryBetter to get on with it, get them out and get on with the things they should be doing:New chairNew, smaller boardNew advisersNew monitorNew commercial modelNew marketing storyDoubt any of this will happen and expect the corinavirus will be blamed for everything rather than being seized as a wonderful opportunity to reinvent, relaunch and reinvigorateAt the risk of droning on, LID did all the New stuff and also took advantage of the pandemic. That is why their H1 sales are FOUR times DEMG's when they were neck and neck two years agoAnd I apologize for not answering your question: don't know date, why don't you ask the company?MrC
mrc2u
03/9/2020
12:22
When do 1st half results come out?
janatha
24/8/2020
11:32
Suspect Lidco are holding estimates back to allow for future upgrades- however there are clearly sceptics out there as LID is on a big discount to DEMG on EV/Sales basis
vega44
24/8/2020
11:18
Hats of to LID, they took real advantage. But note, if new broker estimates for LID were seen to be correct, then sales in H 2 will fall to £3.5m and the H2 loss would be £0.8m.
sidam
24/8/2020
07:11
Well done to LID for a very strong first half. They have taken full advantage of the CoVid gift horse and GROWN their core product sales by 83% to 6.1mDEMG, on the other hand, somehow managed to totally miss the gift horse and saw (yet another) sharp decline in sales to 1.2mFrom parity with LID in 2017 to selling less than one fifth two and a half years later is a truly dreadful performance by DEMGHeads must roll and they must roll now. Absolutely shocking and heaven only knows what this will do to the relative share pricesTerrible start to the week. Although glad I bought a few LID at half the current priceMrC
mrc2u
Chat Pages: 865  864  863  862  861  860  859  858  857  856  855  854  Older
ADVFN Advertorial
Your Recent History
LSE
DEMG
Deltex Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201130 14:25:02